Results 151 to 160 of about 23,997 (201)
Epidermolysis Bullosa Acquisita: A Case Report of a Rare Clinical Phenotype and a Review of Literature. [PDF]
Beiu C +4 more
europepmc +1 more source
Accessible Diagnostic Methods to Differentiate between Epidermolysis Bullosa Acquisita and Other Subepidermal Autoimmune Bullous Diseases. [PDF]
Kridin K.
europepmc +1 more source
Delayed-Onset Localized Bullous Pemphigoid on an Umbilical Hernia Repair Scar: An Example of Ruocco's Immunocompromised Cutaneous District. [PDF]
Tercan E +4 more
europepmc +1 more source
Epidermolysis Bullosa Acquisita
A case of epidermolysis bullosa acquisita (EBA) occurring in a 30 year-old-farmer is described. Diagnosis was suggested by clinical signs (adult-onset of mechano-bullous lesions healing with atrophic scar and milia formation, in absence of family history, photosensitivity and urine darkening); it was confirmed by laboratory data (normal urinary ...
PISANI M +2 more
core +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Management of Epidermolysis Bullosa Acquisita
Dermatologic Clinics, 2011Epidermolysis bullosa acquisita is a rare and debilitating autoimmune mucocutaneous blistering disease caused by autoantibodies directed against type VII collagen or anchoring fibrils in the subepidermal basement membrane zone. Treatment is quite challenging because this disease can be recalcitrant to multiple modalities.
exaly +3 more sources
Epidermolysis Bullosa Acquisita Localized to the Face
A 39-year-old woman had a three-year history of recurrent bullous eruption localized to her left cheek. The diagnosis of epidermolysis bullosa acquisita was confirmed by means of direct immunofluorescence and direct immunoelectron microscopic studies ...
Soo-Chan Kim, Eun-So Lee, G S Choi
exaly +2 more sources
Treatment of Recurrent Epidermolysis Bullosa Acquisita With Tofacitinib.
JAMA dermatology, 2023This case report describes a patient with recurrent epidermolysis bullosa acquisita who was treated with tofacitinib.
Birao Fan, Ming-Yue Wang
semanticscholar +1 more source

